Abiopharma

Owlet to Simplify Capital Structure Through Exchange of Series A and Series B Warrants for Common Stock

scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

Stereotaxis Reports 2025 Second Quarter Financial Results

Arcellx - Arcellx Provides Second Quarter 2025 Financial Results and Business Highlights

AWH Announces Second Quarter 2025 Financial Results

New Form 6-K - SMITH & NEPHEW PLC Filed: 2025-08-07 AccNo: 0001654954-25-009214 Size: 237 KB

Notification from CorMedix Inc.

New Form 144 - CONMED Corp Filed: 2025-08-07 AccNo: 0001959173-25-005029 Size: 4 KB

Merus gibt die Finanzergebnisse für das zweite Quartal 2025 bekannt und informiert über die aktuelle Geschäftsentwicklung

Merus annonce ses résultats financiers pour le deuxième trimestre 2025 et fait le point sur ses activités

New Form 8-K - LINDE PLC Filed: 2025-08-07 AccNo: 0001654954-25-009209 Size: 166 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13G/A - Twist Bioscience Corp Filed: 2025-08-07 AccNo: 0000914208-25-000277 Size: 7 KB

New Form 144 - Pacira BioSciences, Inc. Filed: 2025-08-07 AccNo: 0001959173-25-005028 Size: 5 KB

New Form 6-K - CYBIN INC. Filed: 2025-08-07 AccNo: 0001628280-25-038815 Size: 58 KB

New Form SCHEDULE 13G - Roivant Sciences Ltd. Filed: 2025-08-07 AccNo: 0000895421-25-000492 Size: 12 KB